Global Head, Quantitative Safety & Epidemiology
Novartis Pharma AG
East Hanover, NJ, United States
Jamie Geier is the Global Head of Quantitative Safety and Epidemiology (QSE) at Novartis. In this role, she is responsible for the QSE safety strategies to support clinical development and health authority interactions. She is also the Scientific and Strategic Lead for the Novartis Pregnancy outcomes Intensive Monitoring (PRIM) Initiative as well as a PRIM Steering Committee member. Before joining Novartis in 2020, Jamie was Group Head and Senior Director, Epidemiology Strategist for Inflammation & Immunology at Pfizer, Inc. New York, New York (NY). In this role she lead a team of epidemiologists to deliver regulatory safety strategies with a focus on risk characterization. She has 16 years of pharmaceutical industry experience as an Epidemiology Lead and Strategist for a wide range of drug therapies within Neuroscience, Rheumatology, Medical Dermatology & Gastroenterology. Jamie has extensive regulatory and strategic experience, including epidemiological study design strategies and the use of non-interventional data sources for regulatory decision-making. Jamie received her PhD in Epidemiology from the School of Arts and Sciences, Columbia University, New York, NY and holds a Masters of Public Health, Epidemiology Concentration from the Joseph L. Mailman School of Public Health, Columbia University, New York, NY.
Disclosure information not submitted.
Tuesday, April 25, 2023
11:15 AM – 1:00 PM GMT